Cytokinetics (CYTK) Other Working Capital Changes (2016 - 2025)
Historic Other Working Capital Changes for Cytokinetics (CYTK) over the last 14 years, with Q4 2024 value amounting to $58.4 million.
- Cytokinetics' Other Working Capital Changes rose 45332.28% to $58.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $52.4 million, marking a year-over-year increase of 64637.45%. This contributed to the annual value of $52.4 million for FY2024, which is 64637.45% up from last year.
- Per Cytokinetics' latest filing, its Other Working Capital Changes stood at $58.4 million for Q4 2024, which was up 45332.28% from -$2.6 million recorded in Q3 2024.
- Cytokinetics' Other Working Capital Changes' 5-year high stood at $90.5 million during Q4 2020, with a 5-year trough of -$85.3 million in Q2 2022.
- Over the past 5 years, Cytokinetics' median Other Working Capital Changes value was $642500.0 (recorded in 2023), while the average stood at $4.8 million.
- As far as peak fluctuations go, Cytokinetics' Other Working Capital Changes surged by 895097.85% in 2020, and later crashed by 83221.21% in 2022.
- Cytokinetics' Other Working Capital Changes (Quarter) stood at $90.5 million in 2020, then plummeted by 88.94% to $10.0 million in 2021, then plummeted by 952.81% to -$85.3 million in 2022, then surged by 80.64% to -$16.5 million in 2023, then soared by 453.32% to $58.4 million in 2024.
- Its Other Working Capital Changes was $58.4 million in Q4 2024, compared to -$2.6 million in Q3 2024 and -$10.0 million in Q2 2024.